Sfoglia per Titolo
AXMEDIS Framework for Programme and Publication and On-Demand Production
2005 Kia Ng; Bee Ong;R. Neagle;P. Ebinger;M. Schmucker;I. Bruno;P. Nesi
AXMEDIS Tool Core for MPEG-21 Authoring/Playing
2005 P. Bellini;P. Nesi;D. Rogai;A. Vallotti
AXMEDIS: an MPEG-21 based solution for protected cross media content production and distribution
2006 S. Chellini;T. Martini;P. Nesi
Axonal marker neurofilament light predicts long-term outcomes and progressive neurodegeneration after traumatic brain injury
2021 Neil S. N. Graham, Karl A. Zimmerman, Federico Moro, Amanda Heslegrave, Samia Abed Maillard, Adriano Bernini, John-Paul Miroz, Cornelius K. Donat, Maria Yanez Lopez, Niall Bourke, Amy E. Jolly, Emma-Jane Mallas, Eyal Soreq, Mark H. Wilson, Gavin Fatania, Dylan Roi, Maneesh C. Patel, Elena Garbero, Giovanni Nattino, Camelia Baciu, Enrico Fainardi, Arturo Chieregato, Primoz Gradisek, Sandra Magnoni, Mauro Oddo, Henrik Zetterberg, Guido Bertolini, David J. Sharp
Axonal regeneration of cultured mouse hippocampal neurons studied by an optical nano-surgery system
2012 F. Difato; H. Tsushima; M. Pesce; A. Guiggiani; F. Benfenati; A. Blau; M. Basso; M. Vassalli; E. Chieregatti
AXYSIMMETRIC DROP SHAPE ANALYSIS (ADSA) FOR THE SIMULTANEOUS STUDY OF MECHANICAL AND ELECTRICAL PROPERTIES OF A SELF ASSEMBLED INSOLUBLE MONOLAYER
2000 BUSONI L.; CARLA' M.; LANZI L.; L. DEI; OLIVOTTO M.
Ay 'Abida
2003 A. Gori
Ayyubid reception halls in southern Jordan: towards a ‘Light Archaeology’ of political powers
2019 MIchele Nucciotti; Lorenzo Fragai
Az 1956-os forradalom és a romániai magyarság (1956-1959)
2006 Stefano Bottoni
Az èsz hasznàlatàròl ès az elme ökològiàjàròl
1986 B. Tottossy
Az írói nyelvválasztásról és a művészeti tudásról (Sulla scelta della lingua della scrittura e sul sapere dell'artista)
2013 Tottossy, Beatrix
Aza- and Mixed Thia/Aza-Macrocyclic Receptors with Quinoline-Bearing Pendant Arms for Optical Discrimination of Zinc(II) or Cadmium(II) Ions
2020 Garau A.; Aragoni M.C.; Arca M.; Bencini A.; Blake A.J.; Caltagirone C.; Giorgi C.; Lippolis V.; Scorciapino M.A.
Aza-macrocycles bearing lipophilic functions. Their synthesis and selective lithium complexation
1996 A.Bencini; V.Fusi; C.Giorgi; M.Micheloni; N.Nardi; B.Valtancoli
AZA-Tanshinone derivatives, process for their preparation and their use in therapy
2016 Marco, Fragai; Claudio, Luchinat; Linda, Cerofolini; Fuccio, Carmelo
Azabenzoxazoles: synthesis of 3-methylisoxazolo[5,4-c]- and 2-methyloxazolo[5,4-c]pyridines
1982 A.Camparini; S.Chimichi;F.Ponticelli; P.Tedeschi
Azacitidine for the treatment of lower risk myelodysplastic syndromes : a retrospective study of 74 patients enrolled in an Italian named patient program
2010 Musto, P., Maurillo, L., Spagnoli, A., Gozzini, A., Rivellini, F., Lunghi, M., Villani, O., Aloe-Spiriti, M.A., Venditti, A., Santini, V., Leone, G., Voso, M.T., D'Arco, A.M., Tatarelli, C., Ferrero, D., Gaidano, G., Palumbo, G., Di Raimondo, F., Oliva, E., Sanpaolo, G., Tonso, A., Santagostino, A., Filardi, N., Pollio, B., Candoni, A., Fili, C., Russo, D., Orciuolo, E., Petrini, M., Ciuffreda, L., Riezzo, A., Morabito, F., Mazza, P., Pastore, D., Specchia, G., Ferrara, F.
Azacitidine in lower-risk myelodysplastic sindrome
2009 Santini V
Azacitidine in myelodysplastic syndromes
2005 V.Santini; M.A. Sekeres
Azacitidine Prolongs Overall Survival (OS) and Reduces Infections and Hospitalizations in Patients (Pts) with WHO-Defined Acute Myeloid Leukemia (AML) Compared with Conventional Care Regimens (CCR)
2008 Pierre Fenaux; Ghulam J Mufti; Eva Hellström-Lindberg; Valeria Santini; Norbert Gattermann; Guillermo Sanz; Alan F. List; Steven D. Gore; John F Seymour; Jay Backstrom; Linda Zimmerman; David McKenzie; C. L. Beach; and Lewis B. Silverman
Azacitidine prolongs overall survival and reduces infections and hospitalizations in patients with WHO-defined acute myeloid leukaemia compared with conventional care regimens: an update.
2008 Fenaux P; Mufti GJ; Hellström-Lindberg E; Santini V; Gattermann N; Sanz G; List AF; Gore SD; Seymour JF; Backstrom J; Zimmerman L; McKenzie D; Beach CL; Silverman LB.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| AXMEDIS Framework for Programme and Publication and On-Demand Production | 2005 | Kia Ng; Bee Ong;R. Neagle;P. Ebinger;M. Schmucker;I. Bruno;P. Nesi | |
| AXMEDIS Tool Core for MPEG-21 Authoring/Playing | 2005 | P. Bellini;P. Nesi;D. Rogai;A. Vallotti | |
| AXMEDIS: an MPEG-21 based solution for protected cross media content production and distribution | 2006 | S. Chellini;T. Martini;P. Nesi | |
| Axonal marker neurofilament light predicts long-term outcomes and progressive neurodegeneration after traumatic brain injury | 2021 | Neil S. N. Graham, Karl A. Zimmerman, Federico Moro, Amanda Heslegrave, Samia Abed Maillard, Adriano Bernini, John-Paul Miroz, Cornelius K. Donat, Maria Yanez Lopez, Niall Bourke, Amy E. Jolly, Emma-Jane Mallas, Eyal Soreq, Mark H. Wilson, Gavin Fatania, Dylan Roi, Maneesh C. Patel, Elena Garbero, Giovanni Nattino, Camelia Baciu, Enrico Fainardi, Arturo Chieregato, Primoz Gradisek, Sandra Magnoni, Mauro Oddo, Henrik Zetterberg, Guido Bertolini, David J. Sharp | |
| Axonal regeneration of cultured mouse hippocampal neurons studied by an optical nano-surgery system | 2012 | F. Difato; H. Tsushima; M. Pesce; A. Guiggiani; F. Benfenati; A. Blau; M. Basso; M. Vassalli; E. Chieregatti | |
| AXYSIMMETRIC DROP SHAPE ANALYSIS (ADSA) FOR THE SIMULTANEOUS STUDY OF MECHANICAL AND ELECTRICAL PROPERTIES OF A SELF ASSEMBLED INSOLUBLE MONOLAYER | 2000 | BUSONI L.; CARLA' M.; LANZI L.; L. DEI; OLIVOTTO M. | |
| Ay 'Abida | 2003 | A. Gori | |
| Ayyubid reception halls in southern Jordan: towards a ‘Light Archaeology’ of political powers | 2019 | MIchele Nucciotti; Lorenzo Fragai | |
| Az 1956-os forradalom és a romániai magyarság (1956-1959) | 2006 | Stefano Bottoni | |
| Az èsz hasznàlatàròl ès az elme ökològiàjàròl | 1986 | B. Tottossy | |
| Az írói nyelvválasztásról és a művészeti tudásról (Sulla scelta della lingua della scrittura e sul sapere dell'artista) | 2013 | Tottossy, Beatrix | |
| Aza- and Mixed Thia/Aza-Macrocyclic Receptors with Quinoline-Bearing Pendant Arms for Optical Discrimination of Zinc(II) or Cadmium(II) Ions | 2020 | Garau A.; Aragoni M.C.; Arca M.; Bencini A.; Blake A.J.; Caltagirone C.; Giorgi C.; Lippolis V.; Scorciapino M.A. | |
| Aza-macrocycles bearing lipophilic functions. Their synthesis and selective lithium complexation | 1996 | A.Bencini; V.Fusi; C.Giorgi; M.Micheloni; N.Nardi; B.Valtancoli | |
| AZA-Tanshinone derivatives, process for their preparation and their use in therapy | 2016 | Marco, Fragai; Claudio, Luchinat; Linda, Cerofolini; Fuccio, Carmelo | |
| Azabenzoxazoles: synthesis of 3-methylisoxazolo[5,4-c]- and 2-methyloxazolo[5,4-c]pyridines | 1982 | A.Camparini; S.Chimichi;F.Ponticelli; P.Tedeschi | |
| Azacitidine for the treatment of lower risk myelodysplastic syndromes : a retrospective study of 74 patients enrolled in an Italian named patient program | 2010 | Musto, P., Maurillo, L., Spagnoli, A., Gozzini, A., Rivellini, F., Lunghi, M., Villani, O., Aloe-Spiriti, M.A., Venditti, A., Santini, V., Leone, G., Voso, M.T., D'Arco, A.M., Tatarelli, C., Ferrero, D., Gaidano, G., Palumbo, G., Di Raimondo, F., Oliva, E., Sanpaolo, G., Tonso, A., Santagostino, A., Filardi, N., Pollio, B., Candoni, A., Fili, C., Russo, D., Orciuolo, E., Petrini, M., Ciuffreda, L., Riezzo, A., Morabito, F., Mazza, P., Pastore, D., Specchia, G., Ferrara, F. | |
| Azacitidine in lower-risk myelodysplastic sindrome | 2009 | Santini V | |
| Azacitidine in myelodysplastic syndromes | 2005 | V.Santini; M.A. Sekeres | |
| Azacitidine Prolongs Overall Survival (OS) and Reduces Infections and Hospitalizations in Patients (Pts) with WHO-Defined Acute Myeloid Leukemia (AML) Compared with Conventional Care Regimens (CCR) | 2008 | Pierre Fenaux; Ghulam J Mufti; Eva Hellström-Lindberg; Valeria Santini; Norbert Gattermann; Guillermo Sanz; Alan F. List; Steven D. Gore; John F Seymour; Jay Backstrom; Linda Zimmerman; David McKenzie; C. L. Beach; and Lewis B. Silverman | |
| Azacitidine prolongs overall survival and reduces infections and hospitalizations in patients with WHO-defined acute myeloid leukaemia compared with conventional care regimens: an update. | 2008 | Fenaux P; Mufti GJ; Hellström-Lindberg E; Santini V; Gattermann N; Sanz G; List AF; Gore SD; Seymour JF; Backstrom J; Zimmerman L; McKenzie D; Beach CL; Silverman LB. |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile